Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study

被引:8
作者
Ergul, Bilal [1 ]
Kocak, Erdem [1 ]
Tas, Adnan [1 ]
Filik, Levent [1 ]
Koklu, Seyfettin [1 ]
机构
[1] Ankara Educ & Res Hosp, Ankara, Turkey
关键词
HELICOBACTER-PYLORI; TRIPLE THERAPY; 1ST-LINE TREATMENT; CONSENSUS REPORT; INFECTION; CLARITHROMYCIN; SUBSALICYLATE; ESOMEPRAZOLE; PROTECTION; MANAGEMENT;
D O I
10.1016/j.clinre.2012.10.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:527 / 529
页数:3
相关论文
共 19 条
[1]
Bagchi D, 1998, J APPL TOXICOL, V18, P3
[2]
Effects of in vitro antibiotic resistance on treatment: Bismuth containing regimens [J].
Chiba, N .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 14 (10) :885-889
[3]
THE GASTRODUODENAL MUCUS BARRIER AND ITS ROLE IN PROTECTION AGAINST LUMINAL PEPSINS - THE EFFECT OF 16,16-DIMETHYL PROSTAGLANDIN-E(2), CARBOPOL-POLYACRYLATE, SUCRALFATE AND BISMUTH SUBSALICYLATE [J].
COPEMAN, M ;
MATUZ, J ;
LEONARD, AJ ;
PEARSON, JP ;
DETTMAR, PW ;
ALLEN, A .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1994, 9 :S55-S59
[4]
The effects of sequential treatment as a first-line therapy for Helicobacter pylori eradication [J].
Demir, Mehmet ;
Ataseven, Hilmi .
TURKISH JOURNAL OF MEDICAL SCIENCES, 2011, 41 (03) :427-433
[5]
Eradication of Helicobacter pylori with triple therapy:: An epidetniologic analysis of trends in turkey over 10 years [J].
Kadaylfci, Abdurrahman ;
Buyukhatipoglu, Hakan ;
Savas, M. Cemil ;
Simsek, Ilkay .
CLINICAL THERAPEUTICS, 2006, 28 (11) :1960-1966
[6]
Moxifloxacine Plus Amoxicillin and Ranitidine Bismuth Citrate or Esomeprazole Triple Therapies for Helicobacter pylori Infection [J].
Kilic, Zeki Mesut Yalm ;
Koeksal, Aydin Seref ;
Cakal, Basak ;
Nadir, Isilay ;
Oezin, Yasemin Oezderin ;
Kuran, Sedef ;
Sahin, Burhan .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (12) :3133-3137
[7]
Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report [J].
Malfertheiner, P. ;
Megraud, F. ;
O'Morain, C. ;
Bazzoli, F. ;
El-Omar, E. ;
Graham, D. ;
Hunt, R. ;
Rokkas, T. ;
Vakil, N. ;
Kuipers, E. J. .
GUT, 2007, 56 (06) :772-781
[8]
Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report [J].
Malfertheiner, Peter ;
Megraud, Francis ;
O'Morain, Colm A. ;
Atherton, John ;
Axon, Anthony T. R. ;
Bazzoli, Franco ;
Gensini, Gian Franco ;
Gisbert, Javier P. ;
Graham, David Y. ;
Rokkas, Theodore ;
El-Omar, Emad M. ;
Kuipers, Ernst J. .
GUT, 2012, 61 (05) :646-664
[9]
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial [J].
Malfertheiner, Peter ;
Bazzoli, Franco ;
Delchier, Jean-Charles ;
Celinski, Krysztof ;
Giguere, Monique ;
Riviere, Marc ;
Megraud, Francis .
LANCET, 2011, 377 (9769) :905-913
[10]
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption [J].
Megraud, Francis ;
Coenen, Samuel ;
Versporten, Ann ;
Kist, Manfred ;
Lopez-Brea, Manuel ;
Hirschl, Alexander M. ;
Andersen, Leif P. ;
Goossens, Herman ;
Glupczynski, Youri ;
Alarcon, T. ;
Albrecht, P. ;
Barna, Z. ;
Burucoa, C. ;
Calvet, X. ;
Cambau, E. ;
Cellini, L. ;
Conroy, M-C ;
Deforges, L. ;
Dzierzanowska-Fangrat, K. ;
Franzin, L. ;
Gisbert, J. ;
Gosciniak, G. ;
Huang, Te-Din ;
Jeverica, S. ;
Kuipers, E. ;
Kupcinskas, L. ;
Lario, S. ;
Lawson, A. ;
Marzio, L. ;
McNulty, C. ;
Melby, K. ;
Mentis, A. ;
Monno, R. ;
Montes, M. ;
Oleastro, M. ;
O'Morain, C. ;
Pellicano, R. ;
Perez-Trallero, E. ;
Pieramico, O. ;
Rasmussen, L. ;
Raymond, J. ;
Royo, G. ;
Stoof, J. ;
Szkaradkiewicz, A. ;
Taneike, I ;
Tonkic, M. ;
Villar, Perez H. ;
Wueppenhorst, N. ;
Zanetti, M. .
GUT, 2013, 62 (01) :34-42